A community of 30,000 US Transcriptionist serving Medical Transcription Industry
Patient with marginal zone lymphoma and myeloproliferative disorder
Myeloproliferative disorder with significant fibrosis and a very nice response to (s/l JAK5) _____. And again - I am going to continue the (s/l JAK5) _____ at current dose.